Eliem Therapeutics Stock Quote ELYM - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.79

Bid

6.50

Ask

10.59

Volume

106,416

6.5001 Day's Range 6.82

2.35 52 Week Range 11.55

Market Cap

197.238M

Previous Close

6.78

Open

6.72

Last Trade

250

6.79

(formt)

Last Trade Time

Financial Volume

$ 707,562

VWAP

6.649

Average Volume (3m)

314,339

Shares Outstanding

29,091,166

Dividend Yield

PE Ratio

-5.50

Earnings Per Share (EPS)

-1.21

Revenue

Net Profit

-35.12M

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eliemtx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Eliem Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELYM. The last closing price for Eliem Therapeutics was $6.78. Over the last year, Eliem Therapeutics shares have traded in a share price range of $ 2.35 to $ 11.55.

Eliem Therapeutics currently has 29,091,166 shares outstanding. The market capitalization of Eliem Therapeutics is $197.24 million. Eliem Therapeutics has a price to earnings ratio (PE ratio) of -5.50.

Form 4 - Statement of changes in beneficial ownership of securities

Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes

SEATTLE and CAMBRIDGE, United Kingdom, June 28, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today that the Company will be included in the Russell 2000® Index and...

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

Eliem to focus on advancing TNT119, an anti-CD19 antibody designed to treat a broad range of autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia and membranous...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.4	-5.56328233658	7.19	7.33	6.5001	146332	6.72785632	CS
4	-1.83	-21.2296983759	8.62	9.25	6.5001	198178	7.43948798	CS
12	2.0499	43.2459230818	4.7401	11.55	3.32	314339	7.15478257	CS
26	3.94	138.245614035	2.85	11.55	2.52	482336	5.32660997	CS
52	3.84	130.169491525	2.95	11.55	2.35	252785	5.19921692	CS
156	-9.46	-58.2153846154	16.25	29.69	2.21	134389	6.96883614	CS
260	-9.46	-58.2153846154	16.25	29.69	2.21	134389	6.96883614	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SNGXSoligenix Inc	$ 7.42 (271.00%)	134.15M
ZAPPZapp Electric Vehicles Group Ltd	$ 17.9001 (93.72%)	45.5M
PEGYPineapple Energy Inc	$ 2.30 (91.67%)	77.57M
ATNF180 Life Sciences Corporation	$ 2.9017 (79.12%)	31.21M
QUREuniQure NV	$ 6.65 (75.93%)	51.49M
NVOSNovo Integrated Sciences Inc	$ 0.4874 (-35.44%)	3.12M
FAASDigiAsia Corporation	$ 3.65 (-34.17%)	49.17k
INDVIndivior PLC	$ 10.18 (-33.64%)	2.95M
CLEUChina Liberal Education Holdings Ltd	$ 0.3905 (-31.59%)	9.24M
HUBCWHub Cyber Security Ltd	$ 0.0165 (-31.25%)	1.9k
NVDANVIDIA Corporation	$ 131.38 (2.48%)	287.03M
MAXNMaxeon Solar Technologies Ltd	$ 0.2451 (-9.22%)	233.65M
TSLATesla Inc	$ 262.33 (3.71%)	160.74M
SNGXSoligenix Inc	$ 7.42 (271.00%)	134.15M
INTCIntel Corporation	$ 34.59 (1.77%)	97.8M